Method for treating a patient according to vaccination with eculizumab or eculizumab variant

摘要

The disclosure provides inter alia C5 inhibition comprising administering an effective amount of a C5 inhibitor, such as eculizumab or eculizumab variant, to a patient who will be followed or will be vaccinated with a Neisseria meningococcal type B specific vaccine A method of treating a patient in need of treatment with an agent, or a method for inhibiting the formation of terminal complement in a patient. A method of vaccinating a patient being treated with eculizumab or eculizumab variant, said method being 14 3 days before or after this eculizumab or eculizumab variant administration, wherein said eculizumab or eculizumab variant is administered for the first time A method comprising administering a Neisseria meningococcal type B specific vaccine prior to about 14 days after administration of the composition.